Past-year hallucinogen use in relation to psychological distress, depression, and suicidality among US adults

KH Yang, BH Han, JJ Palamar - Addictive behaviors, 2022 - Elsevier
Background There is renewed interest in the clinical application of hallucinogenic
substances to treat a range of psychiatric conditions. However, there is mixed evidence …

Driving under the influence of cannabis and alcohol: evidence from a national sample of young drivers

CP Salas-Wright, AH Hai, MG Vaughn, JC Hodges… - Addictive …, 2023 - Elsevier
Objective Driving under the influence (DUI) of psychoactive substances is an important
public health and criminal justice issue, impacting the lives of millions of Americans …

[HTML][HTML] Rapid and Prolonged Antidepressant and Antianxiety Effects of Psychedelics and 3, 4-Methylenedioxy-methamphetamine—A Systematic Review and Meta …

D Fluyau, VK Kailasam, N Revadigar - Psychoactives, 2024 - mdpi.com
Background: There is ongoing research into the potential use of psychedelics and 3, 4-
methylenedioxy-methamphetamine (MDMA) as alternatives to commonly used medications …

Heads, seekers, psychonauts, and one-timers: Patterns in stories of psychedelic consumption

C Brooks Dollar - Journal of Drug Issues, 2023 - journals.sagepub.com
Psychedelics are psychoactive substances that alter ordinary states of consciousness. The
US criminalized ingestion of these drugs approximately 60 years ago and use remains …

Matrix-assisted laser-desorption/ionization–mass spectrometric imaging of psilocybin and its analogues in psychedelic mushrooms using a cesium chloride-coated …

H Wang, Y Wang - Analytical and Bioanalytical Chemistry, 2023 - Springer
Fungi with hallucinogenic properties and neurotoxicity have been listed as prohibited drugs
in recent years, but there is a lack of in situ quantification of psilocybin and analogues in …

Examining US National Trends in Adult Mental Illness and Naturalistic Psychedelic Drug Use

D Grossman - 2024 - search.proquest.com
Psychedelic drugs have gained prominent attention in recent years for their therapeutic
potential in treating mental illness in clinical settings. Concurrently, population studies show …

Prevalence and correlates of past year ecstasy/MDMA use in the United States

KH Yang, W Kepner, A Nijum, BH Han… - Journal of addiction …, 2023 - journals.lww.com
Objectives 3, 4-Methylenedioxymethamphetamine (MDMA)(also known as “ecstasy” or
“Molly”) has regained attention in recent years for its efficacy in treating posttraumatic stress …